Inventor · disambiguated record
Joseph E. Payne
Also filed as: PAYNE JOSEPH · PAYNE JOSEPH E
54 granted patents·16 pending applications·611 citations·filing 2005–2025
99Inventor score
Files withARCTURUS THERAPEUTICS INC38NITTO DENKO CORP16KALYPSYS INC6NIITSU YOSHIRO4COSFORD NICHOLAS D2
Top patents by PatentIndex Score
70 records- 0198US10526284B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·16 cites·17 claims
- 0298US9670152B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·52 cites·19 claims
- 0398US9593077B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·88 cites·23 claims
- 0498US9580711B2Lipid particles with asymmetric cationic lipids for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Feb 28, 2017·20 cites·20 claims
- 0598US9567296B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Feb 14, 2017·77 cites·6 claims
- 0698US9365610B2Asymmetric ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·30 cites·17 claims
- 0797US10487105B2Trinucleotide MRNA cap analogsARCTURUS THERAPEUTICS INC·Filed 2017·Granted Nov 26, 2019·19 cites·12 claims
- 0897US9896413B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·19 cites·20 claims
- 0996US10961188B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·7 cites·20 claims
- 1096US10781169B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·6 cites·20 claims
- 1196US10227302B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·12 cites·20 claims
- 1296US9850202B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Dec 26, 2017·15 cites·20 claims
- 1396US9393315B2Compounds for targeting drug delivery and enhancing siRNA activityNIITSU YOSHIRO·Filed 2012·Granted Jul 19, 2016·12 cites·17 claims
- 1496US9011903B2Cationic lipids for therapeutic agent delivery formulationsNIITSU YOSHIRO·Filed 2012·Granted Apr 21, 2015·26 cites·23 claims
- 1595US10980895B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·8 cites·20 claims
- 1695US10233148B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·6 cites·20 claims
- 1795US9963424B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2016·Granted May 8, 2018·8 cites·18 claims
- 1895US9951002B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Apr 24, 2018·12 cites·20 claims
- 1995US9242001B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2014·Granted Jan 26, 2016·14 cites·29 claims
- 2095US8741867B2Retinoid-liposomes for treating fibrosisNIITSU YOSHIRO·Filed 2012·Granted Jun 3, 2014·34 cites·29 claims
- 2195US8664376B2Retinoid-liposomes for enhancing modulation of HSP47 expressionNIITSU YOSHIRO·Filed 2012·Granted Mar 4, 2014·30 cites·26 claims
- 2294US10383952B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 20, 2019·13 cites·16 claims
- 2393USRE49233EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·2 cites·25 claims
- 2493US10815463B2Messenger UNA molecules and uses thereofARCTURUS THERAPEUTICS INC·Filed 2017·Granted Oct 27, 2020·6 cites·19 claims
- 2593US10196637B2Retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·7 cites·20 claims
- 2693US9834510B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·4 cites·20 claims
- 2792US9856475B2Formulations for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jan 2, 2018·5 cites·18 claims
- 2891US10100004B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Oct 16, 2018·4 cites·10 claims
- 2990US11084779B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 10, 2021·2 cites·40 claims
- 3089US9456984B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2014·Granted Oct 4, 2016·10 cites·58 claims
- 3187USRE50681EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2022·Granted Dec 2, 2025·0 cites·38 claims
- 3287US10000447B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Jun 19, 2018·2 cites·16 claims
- 3387US9308267B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2013·Granted Apr 12, 2016·8 cites·21 claims
- 3486US10421964B2UNA oligomers and compositions for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·2 cites·16 claims
- 3586US10399937B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·14 claims
- 3686US8609852B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2012·Granted Dec 17, 2013·12 cites·2 claims
- 3785US10195145B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·4 cites·31 claims
- 3885US9982259B2Transthyretin allele selective UNA oligomers for gene silencingARCTURUS THERAPEUTICS INC·Filed 2015·Granted May 29, 2018·5 cites·29 claims
- 3984US11737979B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2020·Granted Aug 29, 2023·1 cites·19 claims
- 4084US2025304532A1Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4182US10441659B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2015·Granted Oct 15, 2019·3 cites·22 claims
- 4282US7879882B2Thiazolyl mglur5 antagonists and methods for their useMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·4 cites·2 claims
- 4381US10968248B2Trinucleotide mRNA cap analogsC/O ARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 6, 2021·2 cites·18 claims
- 4480US12220485B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 4580US10556861B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·1 cites·15 claims
- 4678US12286395B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2020·Granted Apr 29, 2025·0 cites·18 claims
- 4773US2021323914A1Ionizable cationic lipid for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4872US10669229B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2018·Granted Jun 2, 2020·0 cites·21 claims
- 4971US10532975B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2018·Granted Jan 14, 2020·0 cites·35 claims
- 5069US11103583B2Lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 31, 2021·0 cites·17 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph E. Payne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →